These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
403 related articles for article (PubMed ID: 34203268)
1. Emerging Advances of Nanotechnology in Drug and Vaccine Delivery against Viral Associated Respiratory Infectious Diseases (VARID). Seyfoori A; Shokrollahi Barough M; Mokarram P; Ahmadi M; Mehrbod P; Sheidary A; Madrakian T; Kiumarsi M; Walsh T; McAlinden KD; Ghosh CC; Sharma P; Zeki AA; Ghavami S; Akbari M Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34203268 [TBL] [Abstract][Full Text] [Related]
2. Human respiratory viral infections: Current status and future prospects of nanotechnology-based approaches for prophylaxis and treatment. Dawre S; Maru S Life Sci; 2021 Aug; 278():119561. PubMed ID: 33915132 [TBL] [Abstract][Full Text] [Related]
3. Nanomedicine for the SARS-CoV-2: State-of-the-Art and Future Prospects. Varahachalam SP; Lahooti B; Chamaneh M; Bagchi S; Chhibber T; Morris K; Bolanos JF; Kim NY; Kaushik A Int J Nanomedicine; 2021; 16():539-560. PubMed ID: 33519200 [TBL] [Abstract][Full Text] [Related]
4. Nanotechnology-based antiviral therapeutics. Chakravarty M; Vora A Drug Deliv Transl Res; 2021 Jun; 11(3):748-787. PubMed ID: 32748035 [TBL] [Abstract][Full Text] [Related]
5. Viral Infections of the Upper Airway in the Setting of COVID-19: A Primer for Rhinologists. Yuen E; Gudis DA; Rowan NR; Nguyen SA; Schlosser RJ Am J Rhinol Allergy; 2021 Jan; 35(1):122-131. PubMed ID: 32762250 [TBL] [Abstract][Full Text] [Related]
6. Revolutionizing polymer-based nanoparticle-linked vaccines for targeting respiratory viruses: A perspective. Chan Y; Ng SW; Singh SK; Gulati M; Gupta G; Chaudhary SK; Hing GB; Collet T; MacLoughlin R; Löbenberg R; Oliver BG; Chellappan DK; Dua K Life Sci; 2021 Sep; 280():119744. PubMed ID: 34174324 [TBL] [Abstract][Full Text] [Related]
7. Advances in vaccine delivery systems against viral infectious diseases. Kim D; Wu Y; Kim YB; Oh YK Drug Deliv Transl Res; 2021 Aug; 11(4):1401-1419. PubMed ID: 33694083 [TBL] [Abstract][Full Text] [Related]
8. Polymer-based nano-therapies to combat COVID-19 related respiratory injury: progress, prospects, and challenges. Rana MM J Biomater Sci Polym Ed; 2021 Jun; 32(9):1219-1249. PubMed ID: 33787467 [TBL] [Abstract][Full Text] [Related]
9. An overview on nanoparticle-based strategies to fight viral infections with a focus on COVID-19. Yasamineh S; Kalajahi HG; Yasamineh P; Yazdani Y; Gholizadeh O; Tabatabaie R; Afkhami H; Davodabadi F; Farkhad AK; Pahlevan D; Firouzi-Amandi A; Nejati-Koshki K; Dadashpour M J Nanobiotechnology; 2022 Oct; 20(1):440. PubMed ID: 36209089 [TBL] [Abstract][Full Text] [Related]
10. How can nanotechnology help to combat COVID-19? Opportunities and urgent need. Campos EVR; Pereira AES; de Oliveira JL; Carvalho LB; Guilger-Casagrande M; de Lima R; Fraceto LF J Nanobiotechnology; 2020 Sep; 18(1):125. PubMed ID: 32891146 [TBL] [Abstract][Full Text] [Related]
11. Nanostrategies to Develop Current Antiviral Vaccines. Rodrigues G; Gonçalves da Costa Sousa M; da Silva DC; Berto Rezende TM; de Morais PC; Franco OL ACS Appl Bio Mater; 2021 May; 4(5):3880-3890. PubMed ID: 35006813 [TBL] [Abstract][Full Text] [Related]
12. Various theranostics and immunization strategies based on nanotechnology against Covid-19 pandemic: An interdisciplinary view. Chatterjee S; Mishra S; Chowdhury KD; Ghosh CK; Saha KD Life Sci; 2021 Aug; 278():119580. PubMed ID: 33991549 [TBL] [Abstract][Full Text] [Related]
13. The recent challenges of highly contagious COVID-19, causing respiratory infections: Symptoms, diagnosis, transmission, possible vaccines, animal models, and immunotherapy. Mohapatra RK; Pintilie L; Kandi V; Sarangi AK; Das D; Sahu R; Perekhoda L Chem Biol Drug Des; 2020 Nov; 96(5):1187-1208. PubMed ID: 32654267 [TBL] [Abstract][Full Text] [Related]
14. Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses. Artese A; Svicher V; Costa G; Salpini R; Di Maio VC; Alkhatib M; Ambrosio FA; Santoro MM; Assaraf YG; Alcaro S; Ceccherini-Silberstein F Drug Resist Updat; 2020 Dec; 53():100721. PubMed ID: 33132205 [TBL] [Abstract][Full Text] [Related]
15. Advancement in the development of mRNA-based vaccines for respiratory viruses. Troncoso-Bravo T; Ramírez MA; Loaiza RA; Román-Cárdenas C; Papazisis G; Garrido D; González PA; Bueno SM; Kalergis AM Immunology; 2024 Nov; 173(3):481-496. PubMed ID: 39161170 [TBL] [Abstract][Full Text] [Related]
16. The immunomodulatory effects of probiotics on respiratory viral infections: A hint for COVID-19 treatment? Mahooti M; Miri SM; Abdolalipour E; Ghaemi A Microb Pathog; 2020 Nov; 148():104452. PubMed ID: 32818576 [TBL] [Abstract][Full Text] [Related]